The global demand for Buprenorphine Market is presumed to reach the market size of nearly USD 11977.492 MN by 2028 from USD 4368.09 MN in 2021 with a CAGR of 15.5% under the study period 2022 - 2028.
Buprenorphine is an opioid that plays a major role in treating acute pain management and chronic pain management in patients undergoing treatment for cancer, multiple sclerosis or other life-threatening diseases. It is marketed in various dosage forms such as injectables, sublingual tablets & spray, and transdermal patches.
Market Dynamics
The increasing prevalence of chronic pain is the key factor driving the demand for the buprenorphine market. Moreover, the rising population of opioid-addicted patients fosters the growth of this market. Increasing FDA approval of buprenorphine drugs for medicinal use further pushes the demand for this market. Also, the high prevalence of cancer is expected to fuel the demand for cancer therapies which is projected to develop a significant need for buprenorphine market growth globally. The buprenorphine market is expected to witness prominent growth due to the increasing incidence of multiple sclerosis. The demand in osteoarthritis cases with the increasing geriatric population is expected to boost the growth of the buprenorphine market. However, several adverse effects associated with buprenorphine, such as dizziness, memory loss etc., hamper the growth of the buprenorphine market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of buprenorphine. The growth and trends of buprenorphine industry provide a holistic approach to this study.
Market Segmentation
This section of the buprenorphine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Application
- Analgesic
- Opioid Antagonist
By Route Of Administration
- Injectables
- Sublingual
- Transdermal Patches
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Buprenorphine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Buprenorphine Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the buprenorphine market include Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
